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We have used a proteomics approach to identify sites of phosphorylation in the structural proteins of
the Adenovirus type 2 particle. This protein modiﬁcation might play an important role during infection.
Peptides from highly puriﬁed virus were enriched for phosphorylations and analyzed by liquid
chromatography—high-resolving mass spectrometry. Phosphorylations were identiﬁed in 11 structural
peptides and 29 non-redundant phosphorylation sites were unambiguously assigned to speciﬁc amino
acid. An unexpected result was the ﬁnding of phosphotyrosine in two of the viral polypeptides. The
most highly phosphorylated protein was pIIIa with 12 identiﬁed phosphorylation sites. An identiﬁed
preference for proline or leucine residue ﬂanking the phosphorylation sites downstream suggests that
cellular kinases are involved in many of the phosphorylations. Structural modeling showed that one site
in the hexon is located on the outer side of the virus and could be of importance for the virus when
attaching and entering cells.
& 2012 Elsevier Inc. All rights reserved.Introduction
Protein phosphorylation is one of the most important post-
translational modiﬁcations (PTM) since it regulates many impor-
tant cellular functions. Phosphorylations on viral structural pro-
teins might be important for the infectivity. About a dozen
proteins assemble into the dense structure of adenovirus type 2
(Ad2) (Fig. 1 and Table 1) (Flint, 2001; Russell, 2000). The
sequences of the proteins as well as the number of copies of each
protein in the particle are well known (Stewart et al., 1993; van
Oostrum and Burnett, 1985). Experiments with radioactively
labeled ATP suggest that around 30 phosphate residues are
incorporated per virus particle (Akusjarvi et al., 1978). The protein
pIIIa is reported as phosphorylated in several studies and seems
to carry several phosphorylations (Akusjarvi et al., 1978; Axelrod,
1978; Blair and Russell, 1978; Russell and Blair, 1977; Tsuzuki
and Luftig, 1983). Also the 52K protein (Lucher et al., 1986), pTP
(Kusukawa et al., 1994), pV, pVI, pVII, pIX and pXI (Axelrod, 1978)
proteins and the viral endopeptidase/protease (Chatterjee and
Flint, 1987) are believed to be phosphorylated (full protein names
are given in Table 1). However, the exact positions of thell rights reserved.
iquid chromatography mass
sphorylated threonine; pTyr,
Lind).phosphorylation sites are not described. The virPTM database,
which reports on site-speciﬁc modiﬁcations of viral proteins
(Schwartz and Church, 2010), does not contain any information
about phosphorylated sites in Ad2 virion as well. In contrast,
phosphorylations in many Ad2-encoded non-structural proteins,
e.g., S70, S160 and S161 in DBP (Cleghon et al., 1993), S219 in E1A
(Tsukamoto et al., 1986) and Y26, Y42 and Y59 in E4orf4 (Gingras
et al., 2002) are reported in the database. The replication protein
AdPol in Ad2 has moreover been reported to be phosphorylated
(Ramachandra et al., 1993).
Liquid chromatography–mass spectrometry (LC–MS) is a
powerful tool for studying proteins and their modiﬁcations, and
there are several analytical approaches available for studying
phosphoproteomics (Thingholm et al., 2009). A straightforward
strategy is to cleave proteins into peptides, separate phosphory-
lated from non-phosphorylated peptides, and analyze the phos-
phopeptides by MS. By fragmenting the phosphopeptides in the
instrument, peptide sequences, as well as positions for PTMs, can
be determined. Searching the data in a protein database provides
full information about the proteins comprising the given peptides.
In this study, we applied high-resolving site-speciﬁc MS
analysis using the hybrid ion trap Fourier transform (LTQ-FT)
MS instrument in order to study TiO2-enriched phosphopeptides
in the proteome of the Ad2 particle. Phosphorylated serines
(pSer), threonines (pThr) and tyrosines (pTyr) were recognized.
Identiﬁed phosphopeptides were subjected to kinase-substrate
analysis for ﬁnding consensus sequences matching the motifs of
cellular kinases. Since the three dimensional structures of hexon
Fig. 1. Schematic picture of protein components of the Adenovirus type 2 particle.
The 52K protein is associated with the virus particle but the precise localization is
not known. Modiﬁed from Flint SJ et al. (2000) Principles of Virology, ASM Press,
Washington, DC, with permission.
Table 1
Information on and results from total protein analysis of proteins in the
Adenovirus type 2 virion.
Abbreviation Protein name Number per
viriona
MS
detectionb
Sequence
coverage (%)c
pII Hexon 720 22 37
pIII Penton base 60 3 17
pIIIa Capsid protein
precursor pIIIa
60 14 41
pIV Fiber 36 7 24
pV Minor core protein 15771 8 23
52K Encapsidation
protein 52K
2 12
pVI Capsid protein
precursor pVI
360 5 36
pVII Major core protein 833719 2 14
pVIII Capsid protein
precursor pVIII
12773 3 22
pIX Capsid protein IX 240 1 9
pTP DNA terminal
protein
2 3 6
pX/pm Late L2 mu core
protein
125–160 – –
Protease Protease 20 5 19
a Combined data from Flint 2001 and Stewart et al. (1993).
b Number of unique tryptic peptides detected in total protein analysis of the
Ad2 particle with po0.05.
c Sequence coverage of proteins after total protein analysis of the Ad2 particle.
S. Bergstro¨m Lind et al. / Virology 433 (2012) 253–261254and penton proteins (Fuschiotti et al., 2006; Rux et al., 2003;
Zubieta et al., 2005) as well as the structure of human adenovirion
(Liu et al., 2010; Reddy et al., 2010) are described, it was also
possible to visualize some of the identiﬁed phosphorylations.Fig. 2. Screening of phosphorylations in the Adenovirus type 2 particle using 1-D
SDS-PAGE. (A) Coomassie staining. (B) Phosphostaining.Results and discussion
We have updated the knowledge of the phosphoproteome of the
Ad2 virus particle by identifying phosphorylation sites in 10 dif-
ferent proteins. We used several methods to fractionate the proteins
and phosphorylated peptides. Additionally, several preparations ofAd2 virions highly puriﬁed by at least two CsCl-gradient centrifuga-
tions were investigated. The virus purity was checked with 1-D SDS-
PAGE and consistently small amounts of the 52K protein were
detected. The 52K protein may be derived from immature virus
particles, but was conﬁrmed present also in the middle of the
density band of the mature particle. Initial screening was performed
using 1-D SDS-PAGE analysis (Fig. 2). With the exception of
polypeptides IIIa and IV all proteins in the virus particle were well
resolved (Fig. 2) and all expected proteins were detected with total
protein stain (Coomassie). The 52K protein (molecular weight
47 kDa in NCBI database) was unexpectedly observed below the
45 kDa marker. This could be due to the fact that this major band
observed with MS detection for the 52K protein is a cleavage
product. To get an overview of the phosphorylation status of Ad2
we applied the ProQDiamond phosphostaining technique. The
phosphostaining, like previous studies of virus labeled with phos-
phorus 32P (Akusjarvi et al., 1978; Axelrod, 1978; Kusukawa et al.,
1994; Lucher et al., 1986; Russell and Blair, 1977) indicated that
many of the adenovirus structural proteins are modiﬁed by phos-
phorylation (Fig. 2). The pIIIa protein band was most intensively
stained, followed by weaker staining of the 52K and pIII protein
bands. Also other bands showed weak phosphostaining. The pTP
protein could not be detected with either staining method due to
the low copy number of this protein in the particle.
Mass spectrometry has become one of the standard methods
for analysis of complex protein mixtures and in the next step a
total protein analysis of the virus was performed using LC-MS. So
far MS has been used for studies of viral structural proteins only
in a few cases, e.g., Chelius et al. (2002) characterized all proteins
present in the Ad5 particle by LC-MS. We used the so called
shotgun proteomics approach (Washburn et al., 2001) and in the
crude lysates, 12 of the known proteins in the Ad2 virus particle
could be detected (11 with Z2 peptides per protein) (Table 1)
when precursor ions were analyzed using FTMS and product ions
were formed and analyzed in the ion trap. The number of
identiﬁed proteins agreed with the results from 1-D SDS-PAGE
and total protein staining shown in Fig. 2. Rather few peptides
were detected in pIII, pV and pVII relative to their molecular
weights. For protein pV and pVII this is likely to be due to their
high content of arginine and lysine, resulting in very small
peptides upon trypsin digestion. Therefore we decided to test
another enzyme, the LysC protease, which only cleaves after
lysine. However the results were not improved.
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phorylated peptides. It has been demonstrated that analysis of
phosphorylated peptides is nearly impossible without prior
enrichment (Bodenmiller et al., 2007). Moreover, high resolution
mass spectra are required for reliable identiﬁcation of phosphor-
ylation sites. To perform a comprehensive study of phosphoryla-
tion sites in the Ad2 proteome a number of experiments with
slightly different settings were performed (Fig. 3). Initially, in-gel
digestion was tried out for all protein bands detected on an 1-D
SDS-PAGE and we detected phosphopeptides in pVII (experiment
(exp) 1), 52K (exp 2), pV (exp 3 and 4). Futher, the most successful
approach was to extract proteins from pure preparations of Ad2
virus particles and digest them in-solution into peptides (exp
6-15). To reduce competition from non-phosphorylated peptides,
phosphopeptides were then enriched by using either titanium
dioxide (exp 3–5, 8–13, grey part of the graph in Fig. 3) or by anti-
pTyr antibody (4G10, exp 14–15). Pooling of titanium enrich-
ments (*) (8–10 enrichments) before MS analysis was a key for
increasing the number of detected phosphorylated peptides. An
alternative digestion enzyme, LysC (L), and an alternative frag-
mentation method in the MS analysis, ECD (E) normally advanta-
geous for pSer and pThr, were tested but did not improve the
results. Digestion was otherwise performed with trypsin and CID
fragmentation in the LTQ was applied in the LC-MS analysis usingFig. 3. Visualization of optimization experiments. The cumulative number of
unique phosphopeptides detected with Mascot score 425 was plotted against the
number of experiment. Different experimental conditions are indicated: Titanium
dioxide (grey part of the graph), pooled titanium enrichments (*), LysC digestion
(L) and ECD fragmentation (E).
Table 2
Identiﬁed phosphorylated sequences (Mascot score with po0.05) in the proteome of t
Protein Accession numbera Protein name Site
pIII gi99626173 Penton base S45
pIIIa gi99626172 Capsid protein precursor pIIIa S46
pIIIa gi99626172 Capsid protein precursor pIIIa S46
pIIIa gi99626172 Capsid protein precursor pIIIa S28
pIIIa gi99626172 Capsid protein Precursor pIIIa T47
pV gi99626175 Core protein V T80
pIV gi91494972 Unnamed protein product/ﬁber S34
pIV gi91494972 Unnamed Protein product/ﬁber S32
52K gi99626171 Encapsidation protein 52K Y36
52K gi99626171 Encapsidation protein 52K S30
pVI gi99626176 Capsid protein Precursor pVI T12
pVI gi99626176 Capsid protein precursor pVI S89
pVI gi99626176 Capsid protein precursor pVI S49
pVII gi956160496 pVII protein T72
pVIII gi99626182 Capsid protein precursor pVIII S83
pVIII gi99626182 Capsid protein Precursor pVIII T88
a Some protein accession numbers, suggested by the Mascot search engine, may re
b Top scored sites suggested from Mascot search, site could not be conﬁrmed in m
c Mascot score reported for phosphorylated peptide with po0.05.
d n - deamidated asparagine, s,t,y - phosphorylated serine, threonine, and tyrosinemainly the same setup as for the analysis of total proteins descri-
bed above. The following database search reported potential
phosphorylation sites that we later manually interpreted. To
iterate the experiment, the cumulative number of detected sites
was plotted against the experiment number (Fig. 3). The plateau-
value, indicating that more replicates would likely not improve
the results, corresponds to 64 phosphorylated peptides, with
individual Mascot ion scores 425, and was reached after 15
experiments of which ﬁve comprised pooled enrichments. Phos-
phopeptides generally have low abundance in the sample and
consequently only a few of them could overcome the sensitivity
threshold in each run. The shape of the curve in Fig. 3 where a
number of experiments are required to reach a plateau is there-
fore expected. Furthermore, it is also justiﬁable to consider a
phosphopeptide even if it is only detected in one run. In Mascot,
the ion score for an MS/MS match is based on the calculated
probability, P, that the observed match between the experimental
data and the database sequence is a random event and the
reported Mascot score is 10log(P). The best match is therefore
reported with the highest score. The Mascot score signiﬁcance
threshold is calculated for each dataset, depending on the size of
the database, as the probability of the observed event occurring
by chance is less than 5% (po0.05). For all our runs the signi-
ﬁcance score was between 30 and 42. However, initially we con-
sidered all phosphopeptides with individual Mascot ion scores
425 in order not to exclude randomly missed phosphorylations,
even though also peptides detected with p40.05 were included.
The number of peptides further considered was, however, fewer
since higher stringency was required and we applied following
approaches to ﬁlter and group the 64 potential phosphorylations.
First, 16 peptide sequences were identiﬁed as phosphorylated
(po0.05) although the position of phosphorylation site could not
be established unambiguously (Table 2). An example is shown in
Fig. 4 (left panel) were the phosphorylated amino acids are either
Ser 4 or Thr 5. The problem of correct localization of phosphor-
ylation is well known and one helpful approach is Mascot delta
score (Savitski et al., 2011), which uses the difference between the
Mascot score of the top-scored phosphorylation site and the
alternative phosphorylation site(s). If Mascot delta score 410
(for LC-MS settings in this study) (Savitski et al., 2011) a site is
validated with a FDR o1%. In the example given in Fig. 4 (left
panel) the MD was 0, which agreed with the non-properly
localization of the phosphorylation site upon manual inspection.he Adenovirus type 2 particle but with undeﬁned phosphorylation site.
b Score c Sequenced Delta score
5 50 STsQISNFPVVGAELLPVHSK 1.7
5 48 SDASsPFPSLIGSFTSTR 7.5
9 50 SDASSPFPsLIGSFTSTR 2.7
0 54 EAIGQAHVDEHTFQEITsVSR 5.1
5 54 SDASSPFPSLIGSFtSTR 3.9
50 VLRPGtTVVFTPGER 6.1
9 66 GLEFDTNTsESPDInPIK 0.5
5 54 SsGLnFDNTAIAINAGK 0
1 62 ALAGTGSGDREAESyFDAGADLR 0.7
47 APSPsPTASGGATSAADAAADGDYEPPR 0
2 47 LDPRPPVEEPPPAVEtVSPEGR 2.6
73 VVDGLASGIsGVVDLANQAVQNK 1.8
36 NFGsTIKNYGSK 0
58 NYtPTPPPVSTVDAAIQTVVR 0.2
46 SWPAALVYQEsPAPTtVVLPR 0
44 SWPAALVYQESPAPTtVVLPR 0
fer to Adenovirus type C but protein sequences match also Ad2.
anual conﬁrmation and could have an alternative position.
, respectively.
Fig. 4. Representative MS spectra of identiﬁed phosphorylation sites. The phosphopeptide NFGpS/pTIKNYGSK from pVI protein represents a peptide where the positioning
of the phosphate group cannot be located unambiguously (left panel). All other peaks than m/z 649.5 were magniﬁed 10 times for easier interpretation. The peptide
QAILTLQTpSSSERPR belongs to pVIII with the phosphorylation located on S174 and is an example of a veriﬁed phosphorylation site (right panel). The two times
magniﬁcation of selected peak intensities are indicated in the ﬁgure. Vertical line between amino acids in the sequence schemes under the panes means the cleavage site.
Dashes pointing toward N-terminus mean b-ions and pointing toward C-terminus indicate y-ions. Arrows mean the loss of H3PO4 from the corresponding ion and a dash
ending up with a dot means a loss of NH3 from the corresponding b-ion.
S. Bergstro¨m Lind et al. / Virology 433 (2012) 253–261256Second, 29 speciﬁc sites of phosphorylations (po0.05) were
identiﬁed after manual inspection of the recorded mass spectrum
(Kinter and Sherman, 2000) and/or by having a MD score 410
(Table 3, all spectra are provided in Supplementary information).
An example of such veriﬁcation is displayed in Fig. 4 (right panel)
where the phosphorylation site was unambiguously localized at
Ser 9 although MD¼5, i.e., MDo10. Actually, six of the manually
veriﬁed phosphorylation sites had MD scores o10, showing that
manual validation can increase the number of sites accepted
(Table 3).
Taken together, our results showed that the phosphorylation
sites/sequences belong to 11 different proteins (Tables 2 and 3),
and six of them had multiple phosphorylations. In total we
identiﬁed 20 pSer, 5 pThr and 2 pTyr sites. Noteworthy, as many
as 12 phosphorylation sites were detected in pIIIa protein. We
compared our results with previous literature and the VirPTM
database (Schwartz and Church, 2010) describing both identiﬁed
and predicted phosphorylation sites in viral proteomes. For the
Ad2 proteome no phosphorylation sites in structural proteins are
present demonstrating that all identiﬁed phosphorylation sites in
this study are novel. When comparing our identiﬁed phosphor-
ylation sites and phosphopeptide sequences (see Tables 2 and 3)
with predicted phosphorylation sites in the VirPTM database, only
four of the identiﬁed phosphorylation sites in Table 3, namely
Y956 in pII, S351 in pIV, S118 in pVIII, and S319 in pTP protein
were predicted by VirPTM. Additionally, the suggested sites S455
in pIII and S30 in 52K protein in Table 2, were predicted. For pIIIa
protein the high intensity of the band after phosphostaining
(Fig. 2) agreed well with the high number of identiﬁed phosphor-
ylation sites (one pTyr, one pThr and ten pSer), by MS analysis. Six
of the veriﬁed sites (Table 3) cluster in the region between amino
acids 444 to 473. Kusukawa et al. (1994) suggested that pTPprotein contains multiple phosphorylated serines. We detected
one phosphorylation, S319, in pTP. However, since pTP is present
in very few copies per virus particle (Table 1) it has to compete
with peptides from the other, more abundant, proteins in the MS
analysis, lowering the chance of detecting multiple sites in this
protein. For 52K protein, the ﬁnding of phosphorylation (Lucher
et al., 1986) was conﬁrmed in this study since two phosphory-
lated serine residues, S75 and S360 were identiﬁed. For pIII
protein, which stains well with phosphostain, no phosphorylation
site could be detected with a high-quality mass spectrum. How-
ever, a phosphorylated sequence was detected in the 453–473
region of the protein (Table 2) and the top-scored site S455 is also
predicted in the VirPTM database. The ﬁnding of phosphosites in
pII, pIV, pV, pVI, pVII, pVIII and pIX proteins (Table 3) shows that
phosphorylation is more common in the virus particle than it has
been described before.
Two tyrosine phosphorylations were identiﬁed (Table 3), Y490
in pIIIa protein and Y956 in hexon protein. The Y956 was
predicted in the virPTM database (Schwartz and Church, 2010).
Tyrosines are usually evolutionarily conserved, and VirPTM data-
base shows that the Y956 site has conserved ﬂanking sequences
in several serotypes (1, 5 and 7) and in subgroups A and C of
Adenovirus. The site was also predicted to be phosphorylated in
all serotypes and subgroups in the virPTM database. For the Y490
site in the pIIIa protein, the ﬂanking sequences are conserved in
subgroup C (serotypes 1, 2, and 5), although the site was not
predicted to be phosphorylated in these serotypes. The site is,
however, predicted for subgroups D and G members and for
serotype 7 with similar but not totally overlapping ﬂanking
sequences. Generally, the sequences ﬂanking the phosphorylation
sites in Ad2 were in nearly all cases conserved in Ad5. Only two
sites were unique for one of the serotypes.
Table 3
Veriﬁed phosphorylation sites in the proteome of the Adenovirus type 2 virion.
Protein Accession
numbera
Protein name Site Scoreb Sequencee No of
runs
MD
score
Degree of
phosphorylation (%)
pII gi99626177 Hexon S182 43 THVYAQAPLsGETITK 3 8.7 0.80
pII gi99626177 Hexon S283 62 VDLQFFSNTTsLNDR 3 7.9 15
pII gi99626177 Hexon Y956 48 GVIETVyLR 1 24.2 N/a
pIIIa gi99626172 Capsid protein precursor pIIIa S225c 49 ATVsSLLTPNSR 1 10.8 N/a
pIIIa gi99626172 Capsid protein precursor pIIIa S310c 44 IPsLHSLNSEEER 2 26 N/a
pIIIa gi99626172 Capsid protein precursor pIIIa S444c 44 KEsFRRPSSLSDLGAAAPR 2 19.3 N/a
pIIIa gi99626172 Capsid protein precursor pIIIa S449c 43 ESFRRPsSLSDLGAAAPR 3 11.9 43
pIIIa gi99626172 Capsid protein precursor pIIIa S450 67 RPSsLSDLGAAAPR 3 11.6 45
pIIIa gi99626172 Capsid protein precursor pIIIa S452 32 KESFRRPSSLsDLGAAAPR 2 10.5 N/a
pIIIa gi99626172 Capsid protein precursor pIIIa S469c 34 d SDASSPFPsLIGSFTSTR 3 10.3 N/a
pIIIa gi99626172 Capsid protein precursor pIIIa S473 71 SDASSPFPSLIGsFTSTR 2 3.3 N/a
pIIIa gi99626172 Capsid protein precursor pIIIa S494 44 LLGEEEYLNNsLLQPQR 2 25.4 N/a
pIIIa gi99626172 Capsid protein precursor pIIIa S515 30 NLPPAFPNNGIEsLVDK 1 30 N/a
pIIIa gi99626172 Capsid protein precursor pIIIa T274 38 EAIGQAHVDEHtFQEITSVSR 1 25.8 N/a
pIIIa gi99626172 Capsid protein precursor pIIIa Y490 76 LLGEEEyLNNSLLQPQR 1 47.3 71
pIV gi91494972 Unnamed protein product/ ﬁber S351 50 GLEFDTNTSEsPDINPIK 1 16.8 N/a
pV gi99626175 Core protein V S166 45 REsGDLAPTVQLMVPK 3 22.4 N/a
pV gi99626175 Core protein V T85 35 VLRPGTTVVFtPGER 2 35 N/a
52K gi99626171 Encapsidation protein 52K S360 61 EAEsYFDAGADLR 1 10.7 N/a
52K gi99626171 Encapsidation protein 52K S75 31 LGAPsPER 2 31 N/a
pVI gi99626176 Capsid protein precursor pVI S124 64 LDPRPPVEEPPPAVETVsPEGR 2 8.4 N/a
pVI gi99626176 Capsid protein precursor pVI T143 68 EETLVtQIDEPPSYEEALK 2 23.6 N/a
pVII gi956160496 pVII protein T74 80 NYTPtPPPVSTVDAAIQTVVR 3 20.0 N/a
pVII gi99626174 Major core protein S185 31 DSVsGLR 1 13.4 0.013
pVIII gi99626182 Capsid protein precursor pVIII S118 36 VRsPGQGITHLK 3 14.8 N/a
pVIII gi99626182 Capsid protein precursor pVIII T64 31 ILLEQAAITTtPR 1 9.3 N/a
pVIII gi99626182 Capsid protein precursor pVIII S174 67 QAILTLQTsSSEPR 2 4.8 N/a
pIX gi99626166 Capsid protein IX S135 52 QQVSALKASsPPNAV 1 27.5 N/a
pTP gi9135598 DNA terminal protein (Alternative names: Bellett
protein; pTP protein)
S319 42 CIVSAVSLPHGsPPPTHNR 1 17.3 N/a
a Some protein accession numbers, suggested by the Mascot search engine, may refer to Adenovirus type C but protein sequences also match Ad2.
b Scores belong to Mascot score for peptide identiﬁcation, all scores are reported with po0.05.
c Phoshorylation site veriﬁed due to a Mascot delta score 410.
d Mascot score has p40.05, but peptide is kept in the list due to a high Mascot delta score.
e s,t,y - phosphorylated serine, threonine, tyrosine, respectively.
Fig. 5. WebLogo analysis of amino acids surrounding the identiﬁed phosphory-
lated sites in the proteome of the Adenovirus type 2 particle. The frequency of
each amino acid residue present at a certain position is proportional to its height.
A preference for a proline or a leucine was identiﬁed at the þ1 position.
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phosphorylation or phosphorylation occupancy of a speciﬁc
phosphorylation site. This could just be calculated for a limited
number of phosphorylated sites detected in experiments without
enrichment (see Fig. 3, experiment 1, 2, 6, 7) since enrichment
would not reﬂect the native conditions. In these runs we were
able to identify six pairs of phosphorylated/non-phosphorylated
peptides. The values of phosphorylation occupancy are listed in
Table 3. Generally, the degree of phosphorylation was varying
between 1% and 71% with a median value of 15%. This is a quite
high value and agrees with the fact that among the peptides in
Table 3, 18 were reported in more than one MS analysis. This
means that any phosphorylated residue is likely to have an im-
pact on a signiﬁcant portion of the virions in a typical population.
There is a kinase associated with the Ad2 virus particle known
to preferentially phosphorylate pIIIa protein (Akusjarvi et al.,
1978; Blair and Russell, 1978; Tsuzuki and Luftig, 1985a). Its
speciﬁcity is altered depending on presence of different divalent
cations (Tsuzuki and Luftig, 1985b) and under some conditions
also pV and pVII serve as substrates. However, when Cuillel et al.
(1987) produced pIIIa protein in Escherichia coli, they observed a
high level of phosphorylation of this protein as a result of
endogenous protein kinase activity in the bacterial cells. It is
likely that many of the phosphorylations identiﬁed in this study
are mediated by cellular kinases, active in the HeLa cells during
the production of virus. It has been demonstrated that the Ad2
replication protein AdPol can be phosphorylated by cell division
control protein 2 (CDC2) kinase and/or an associated protein
which phosphorylates histone H1 (Ramachandra et al., 1993;
Ramachandra and Padmanabhan, 1993). Dephosphorylation ofAdPol with calf intestine alkaline phosphatase resulted in a
signiﬁcant decrease in its activity in the in vitro DNA replication
initiation assay and a moderate decrease in the DNA polymerase
activity, suggesting that phosphorylation is important for its
biological activity (Ramachandra et al., 1993). To get deeper
knowledge of the phosphorylation process, we applied the
WebLogo and NetPhorest analyses to study the regions ﬂanking
the phosphorylation sites. The WebLogo analysis is a valuable tool
for investigating if there are preference for certain amino acids in
regions that ﬂank the phosphorylation sites and it showed
preference for proline or leucine residue at the þ1 position
(downstream) of the phosphorylation site (Fig. 5). The ﬂanking
Table 4
Results from kinase-substrate analysis via NetPhorest for veriﬁed phosphorylation
sites (Table 3) in the Ad2 proteome.
Protein Site Top-scored kinasea Substrate motif Posterior probability
pVI T143 ATM ATR group EETLVtQIDEP 0.39
pV T85 CDK2/CDK3 group TTVVFtPGERS 0.37
pTP S319 CDK2/CDK3 group SLPHGsPPPTH 0.38
pVIII T64 CDK2/CDK3 group AAITTtPRNNL 0.38
pIX S135 CDK2/CDK3 group ALKASsPPNAV 0.38
pVII T74 CDK2/CDK3 group RNYTPtPPPVS 0.38
pIIIa S515 CK2 group NNGIEsLVDKM 0.14
pII S182 CK2 group AQAPLsGETIT 0.16
pIIIa T274 CK2 group HVDEHtFQEIT 0.17
52K S360 CK2 group DREAEsYFDAG 0.45
pIIIa S450 CLK group FRRPSsLSDLG 0.36
pIIIa S452 DMPK group RPSSLsDLGAA 0.10
pIIIa S449 DMPK group SFRRPsSLSDL 0.31
pIIIa S225 GSK3 group DRATVsSLLTP 0.17
pIIIa S469 MAPKAPK group SSPFPsLIGSF 0.15
pIIIa S494 NEK groupb EYLNNsLLQPQ 0.20
pII S283 NEK groupb FSNTTsLNDRQ 0.21
pIIIa S473 NEK groupb PSLIGsFTSTR 0.22
pVI S124 p38 group AVETVsPEGRG 0.31
pIV S351 p38 group TNTSEsPDINP 0.33
52K S75 p38 group RLGAPsPERHP 0.34
pVIII S118 p38 group RHRVRsPGQGI 0.34
pV S166 PKA group GLKREsGDLAP 0.17
pIIIa S310 PKC group RQKIPsLHSLN 0.24
pIIIa S444 PKC group ALRKEsFRRPS 0.41
pIIIa Y490 Src group LGEEEyLNNSL 0.09
pII Y956 EGFR group VIETVyLRTPF 0.07
a For each phosphorylation site the kinase with highest probability for
performing the phosphorylation is reported.
b NEK1 NEK5 NEK3 NEK4 NEK11 NEK2 group.
Fig. 6. Structural modeling of phosphorylation sites in pII. Crystal structures of the
pII (PDB accession numbers 1DHX (hexon)) were used for modeling of S182 and
Y956 phosphorylation sites. The picture shows a triplet of hexons oriented in the
same way as it appears in the virus particle with the tyrosine amino acid 956 is
labeled in red.
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kinases by NetPhorest kinase-substrate analysis (Miller et al.,
2008), a web based collection of sequence-based classiﬁers for
linear motifs in phosphorylation-dependent signaling in humans.
The result is shown in Table 4 where the kinase with the highest
probability to carry out the phosphorylation is reported for each
phosphorylation site. However in many cases alternative kinases
had nearly identical probabilities. Five of the phosphorylation
sites had the CDK2/CDK3 kinase group as their top-scoring kinase
with posterior probabilities (PP40.35). Two more groups were
identiﬁed with four phosphorylation sites clustered to each
kinase, the p38 group (PP40.30) and the CK2 group (PP: 0.14–
0.40). For example, it has been reported that pTP protein carries
consensus sequences for both cyclin-dependent kinase and casein
kinase II (Ramachandra and Padmanabhan, 1995). This agrees
with our ﬁnding of the S319 site (see sequence in Table 3). Net-
Phorest predicts that this site contains a substrate sequence for
the CDK2/CDK3 group (highly similar to CDC2 protein). Kusukawa
et al. (1994) showed that calf alkaline intestine phosphatase
treatment of pTP protein reduced its activity in an in vitro DNA
replication assay. Also for the phosphorylation sites T85 in pV
protein, T74 in pVII protein, T64 in pVIII protein and S135 in pIX
protein the best candidate kinase is the CDK2/CDK3 group with a
PP40.35 (Table 4). All these phosphosites have proline in their
amino acid sequence downstream of the phosphorylated site,
which matches the consensus sequence for the CDK2/CDK3 group
as revealed by WebLogo and NetPhorest. Also sites phosphory-
lated by p38, a mitogen activated protein kinase have proline in
their amino acid sequence directly after the phosphorylated
residue according to the NetPhorest analysis. Therefore it is not
surprising that all sites that have the top scores for the CDK2/
CDK3 group have the p38 group as the second highest scoring
group and vice versa. For the pTyr sites tyrosine kinases, e.g.,
EGFR and Src were suggested but with a low probability (PPo0.1)(Table 4).The two tyrosine phosphorylation sites displayed low PP
values in the NetPhorest analysis probably because the regions
ﬂanking pTyr sites appear to be more diverse compared to serine
and threonine phosphorylated sites (Beausoleil et al., 2006;
Bergstrom Lind et al., 2011; Salvi et al., 2010).
If phosphorylations are essential for the virus to attach and
enter cells they ought to be located on the outer surface of the
virus particle. Two proteins, pII and pIII, contain phosphorylation
sites which could be located in the crystal structures (Rux et al.,
2003; Zubieta et al., 2005). Using structural data of hexon (pII) in
the PDB-ﬁle and freeware programs, it was possible to model two
of the three identiﬁed phosphorylations, S182 and Y956 (S282
was not present). Viewing a hexon triplet positioned in the same
way as it appears in the particle, the tyrosine site was located on
the upper/outer part (Fig. 6). The serine site was positioned in the
lower/inner part and could not be visualized in the view in Fig. 6.
It should be stressed that Fig. 6 presents the native Tyr residue
labeled in red rather than a re-modeled structure of hexon with a
pTyr site. The tyrosine site might therefore be more important for
the infectivity than the serine site since it is positioned on the
outer side of the virus particle. On the other hand, phosphoryla-
tions in pIII and pIV might be more relevant for the infectivity.
Attachment and binding of both the ﬁber and the penton base to
cellular receptors make them major players in Ad2 internaliza-
tion. Modeling of the S455 site in the pIII protein showed that this
site is positioned at a far distance from the pIV attachment site. It
is therefore more likely that this site is positioned towards the
inside of the virus particle. This claim, however, needs to be
conﬁrmed with more advanced structural modeling techniques.
As discussed by Blair and Russell (1978), phosphorylations of core
proteins, pV and pVII, may be important for binding of these
proteins to the viral DNA as a way of controlling virus
transcription.
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prompts many new questions. Future studies should look into
whether the phosphorylations are needed for the infectivity, have a
functional role in the life cycle of the virus or are needed for assembly
of the virion. In a pilot study we treated virus with calf intestine
phosphatase. Even when using as much as 40 units of enzyme per
estimated mg of virus protein, no reduction in infectivity was detected
(data not shown). However, since the phosphatasemight be unable to
penetrate the intact virus particles, the results are not conclusive.
Another question is when and how the phosphorylations take place.
In this study we suggest that many of the identiﬁed phosphorylation
sites are substrates of cellular kinases. This may indicate that
phosphorylation takes place before the assembly of the virion. A ﬁnal
point to consider is that the phosphorylation of the viral structural
might be a target for anti-viral drugs.Materials and methods
Chemicals
All chemicals were from Sigma-Aldrich (St. Louis, MO, USA) if
not otherwise stated.
Production and puriﬁcation of virus
HeLa spinner cells were grown in (4 L) minimum essential
medium (MEM), spinner modiﬁcation (Invitrogen, Paisley, UK)
and infected with Ad2 (group Human Adenovirus type C) virus for
72 h. Infected cells were spun down, suspended in 40 mL of
10 mM Tris–HCl pH 7.9, and frozen at 80 1C. Upon puriﬁcation,
cells were lysed either in 1/10 volume of 5% sodiumdeoxycholate
and sonicated (315 s on ice), or mixed with an equal volume of
tetrachloroethylene followed by vigorous shaking until a single
phase formed. Cell debris was pelleted by centrifugation and the
supernatant was collected.
Virus was puriﬁed by discontinuous CsCl gradient centrifugation.
First, 6 mL of CsCl with the density of 1.41 was added to a centrifuge
tube and gently overlaid with 10mL of CsCl with the density of 1.27.
The virus lysate was then added on the top of the CsCl layers.
Centrifugation was performed at 25,000 rpm, for 2 h at 4 1C using a
Thermo Scientiﬁc Sorvall WX Ultra series centrifuge, equipped with a
AH-629 rotor (Thermo Fischer Scientiﬁc, Waltham, MA, USA). The
virus band was collected by dripping the solution slowly out of the
bottom of the tube. The virus was further puriﬁed by continuous CsCl
gradient centrifugation as follows. The band was transferred to a new
centrifugation tube which was ﬁlled up with CsCl with the density
of 1.34. Ultracentrifugation was then performed at 25,000 rpm for
18–22 h at 4 1C. Virus was collected and dialysed against 10 mM
Tris–HCl, pH 8.0 at 4 1C overnight and then stored at 80 1C. Virus
purity was checked by 1-D SDS-PAGE and Coomassie staining.
SDS-PAGE analysis
Puriﬁed virus was mixed with Laemmli sample loading buffer
and a series of sample dilutions were analyzed using 1-D SDS-
PAGE (13% gel, cast in house) followed by ProQDiamond staining
(Molecular Probes, Invitrogen, Carlsbad, CA, USA). Phosphoryla-
tions were visualized using a ﬂuorescent imager (Typhoon Ima-
ger, GE Healthcare, Uppsala, Sweden). Afterwards gels were
Coomassie stained for total protein visualization.
Lysis and digestion
In-gel digestion. Puriﬁed virus was mixed with Laemmli sample
loading buffer and analyzed with 10 or 13% 1-D SDS-PAGE usingCoomassie staining. Individual protein bands were cut out from the
gel and digested by trypsin or Lys-C as described by Shevchenko
et al. (2000). Brieﬂy, gel pieces were destained, reduced with
dithiothreitol and alkylated with iodoacetoamide. Incubation with
trypsin (Promega, Madison, WI, USA) or Lys-C (Sigma-Aldrich)
solution (12.5–25 ng/mL in 50 mM NaHCO3) was performed over
night, at 37 1C in the dark. Tryptic peptides were extracted using
sonication or by adding 50% ACN in 0.1% triﬂuouroacetic acid (TFA).
Samples were ﬁltered through a 10 kDa molecular weight cut-off
(MWCO) ultraﬁltration unit (Millipore, Billerica, MA, USA), desalted
using Stage-Tip technology (Rappsilber et al., 2003) with Empore
Disks C18 from Varian (Palo Alto, CA, USA) and dried in a Speedvac.
In-solution digestion: virus was lysed in the solution of 9M urea,
20 mM HEPES, 2.5 mM sodium pyrophosphate, 1 mM b-glyceropho-
sphate and 1mM sodium vanadate, prepared by adding reagents
directly to puriﬁed virus solution. Volume was adjusted with Milli-Q
water to reach the ﬁnal concentrations listed above. A small aliquot
was set aside for protein concentration determination using BCA
(Pierce, Rockford, IL, USA). After sonication and centrifugation in order
to remove unlysed material, carbamidomethylation was performed
using dithiothreitol and iodoacetoamide. Samples were diluted four
times to reduce urea content and then digested with trypsin
(trypsin:protein ratio 1:50, Promega) overnight at room temperature.
Samples were ﬁltered through a 10 kDa MWCO ultraﬁltration unit
(Millipore, Billerica, MA, USA), desalted using Stage-Tip technology
(Rappsilber et al., 2003) with Empore Disks C18 from Varian (Palo
Alto, CA, USA) and dried in a Speedvac.
Phosphopeptide enrichment
Titanium dioxide enrichment: Tryptic peptides were loaded on
SpinTip columns with TiO2 packing (GL Sciences Inc., Tokyo,
Japan) according to the protocol supplied by the manufacturer.
Brieﬂy, TiO2 tips were conditioned and equilibrated with Buffers A
(0.4% triﬂuoroacetic acid (TFA), 80% acetonitrile and 19.6% Milli-Q
water) and B (25% lactic acid, 60% acetonitrile, 0.3% TFA, 14.7%
Milli-Q water). Tryptic peptides were dissolved in Buffer B and
added to the tip in two repeated loadings. A maximum load of
50 mg of viral total protein digest was used per tip. For enrich-
ment of peptides from selected bands, pools from around 10
bands were applied to each tip. Tips were then rinsed with Buffer
B and A, and enriched peptides were eluted in two steps using 5%
ammonium hydroxide and then 5% pyrrolidine. Pooled eluates
were acidiﬁed and desalted using the StageTip procedure (see
lysis and digestion) before being concentrated in a Speedvac.
Immunoafﬁnity enrichment: For speciﬁc enrichment of tyro-
sine phosphorylated peptides, 1.2 mg of tryptic digest of total
virus proteins was loaded onto beads coupled with the anti-pTyr
antibody 4G10 (40 mg antibody/mL beads) as described before
(Bergstrom Lind et al., 2012). After incubation, peptides were
eluted with 0.1% TFA, ﬁltered through 10 kDa MWCO Amicon
ultraﬁltration units (Millipore) and then puriﬁed using StageTip
procedure (see lysation and digestion).
LC-MS analysis and peptide identiﬁcation
A 7-tesla LTQ-FT Ultra tandem mass spectrometer (Thermo-
Fisher Scientiﬁc) modiﬁed with a nano electrospray ion source
(Proxeon Biosystems) was used for all analyses. The samples were
diluted in water/TFA (1:0.005 v/v), and peptides were separated
by Agilent 1100 nanoﬂow system equipped with homemade
15-cm fused silica emitter packed with Reprosil-Pur C18-AQ 3 mm
resin (Dr. Maisch GmbH), and coupled on-line to the mass spectro-
meter. Peptides were eluted with a 90-min linear gradient from 2%
to 45% acetonitrile at 200 nL/min. The mass spectrometer was
operated in positive ion mode and during each run it automatically
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survey mass spectrum in the FTMS cell and consecutive (i) high-
resolved (25,000) electron capture dissociation (ECD) and colli-
sionally induced dissociation (CID) spectra of two most abundant
ions in FTMS, or (ii) low resolution CID spectra of the 5 most
abundant ions in the ion trap. CID was performed with helium as a
collision gas (pressure 0.1 Pa), normalized collision energy was set
to 30%. A dynamic exclusion for 30 s for 5 peptides was used as
well. The acquired data (.RAW-ﬁles) were converted by in-house
written program to Mascot generic format ﬁles. Peptide identiﬁca-
tion was performed using the Mascot search engine (version 2.1.3,
Matrix Science) by searching the NCBI database with set ‘‘Viruses’’
taxonomy. Searches were performed with trypsin speciﬁcity and
up to two missed cleavages were allowed. Mass deviation for
precursor ions was set to 10 ppm. For fragment ions the mass
deviation was set to 0.7 Da. Carbamidomethylation was chosen
as a ﬁxed modiﬁcation, while deamidation (N, Q), oxidation (M),
phosphorylation (S, T), and phosphorylation (Y) were set as
variable modiﬁcations. Finally, the instrument setting was ‘‘ESI-
FTICR’’. The peptide/protein identiﬁcations were based on MudPIT
scoring.
Data analysis
Only phosphopeptide identiﬁcations with Mascot score higher
than 25 were taken into consideration and further subjected to
manual inspection in order to conﬁrm the proposed phosphoryla-
tion sites. The corresponding mass spectra were checked for
presence of cleavage site peaks with signal-to-noise ratio exceed-
ing 3 which reveal the presence of phosphoserine, phosphothreo-
nine, or phosphotyrosine. Additionally, Mascot delta (MD) scores
were calculated for all suggested phosphosites by ﬁnding the
difference between the top two Mascot ion scores of alternative
phosphorylation sites in the same peptide sequence (Savitski et al.,
2011). If a phosphorylation site was not conﬁrmed by manual
inspection, but had a MD score exceeding 10, this site was also
considered as conﬁrmed with a false discovery rate (FDR) o1%.
In order to semi-quantify a degree of phosphorylation(pho-
sphorylation occupancy rate), RAW ﬁles from MS runs were ﬁrst
deconvoluted from all charges using XTract software (Thermo-
Fisher Scientiﬁc). Then mass chromatograms were manually
reconstructed for pairs of phosphorylated/non-phosphorylated
peptides using the molecular weight values reported by Mascot
for these peptides. Mass chromatograms were integrated, and
peak areas corresponding to non-modiﬁed and all modiﬁed ver-
sions of the same peptide sequence were acquired. The phosphor-
ylation occupancy was then calculated as a ratio between the
peak area of given phosphopeptide and a sum of all peak areas
representing the same peptide sequence.
To investigate if a phosphorylation site was new we used the
Swiss-Prot database (http://www.expasy.org/spot) and the
VirPTM database (Schwartz and Church, 2010) (http://virptm.
hms.harvard.edu/). Also the phosphorylations predicted by
VirPTM database were taken into consideration. Analysis of the
frequencies of amino acids ﬂanking the phosphorylation sites in
Table 3 was performed using the WebLogo tool (http://weblogo.
berkeley.edu/logo.cgi) (Crooks et al., 2004). Kinase-substrate
relationships were predicted via the NetPhorest algorithm (ver-
sion 2011 contains 125 sequence-based classiﬁers and covers 179
of 518 kinases) (Miller et al., 2008) for veriﬁed phosphorylation
sites in Table 3. Crystal structures of the pII (hexon) and the pIII
(penton base) proteins in Ad2 were available in the PDB database
(www.rcsb.org )(PDB accession numbers 1DHX (Rux et al., 2003)
and 1X9P (Zubieta et al., 2005)) and were used for modeling of
S182 and Y956 in the pII protein and S455 in the pIII protein. The
software Swiss-PdbViewer (http://spdbv.vital-it.ch/) and RasMol(http://rasmol.org/), both distributed as freeware, was used for
monitoring the positions of phosphorylations.Acknowledgments
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